JPMorgan Chase & Co’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $266K | Sell |
|
|||||
|
2025
Q1 | $1.88M | Sell |
|
|||||
|
2024
Q4 | $2.93M | Buy |
|
|||||
|
2024
Q3 | $345K | Buy |
|
|||||
|
2024
Q2 | $249K | Sell |
|
|||||
|
2024
Q1 | $227K | Sell |
|
|||||
|
2023
Q4 | $289K | Sell |
|
|||||
|
2023
Q3 | $242K | Buy |
|
|||||
|
2023
Q2 | $242K | Sell |
|
|||||
|
2023
Q1 | $891K | Buy |
|
|||||
|
2022
Q4 | $170K | Buy |
|
|||||
|
2022
Q3 | $133K | Buy |
|
|||||
|
2022
Q2 | $173K | Buy |
|
|||||
|
2022
Q1 | $175K | Buy |
|
|||||
|
2021
Q4 | $166K | Buy |
|
|||||
|
2021
Q3 | $161K | Buy |
|
|||||
|
2021
Q2 | $105K | Sell |
|
|||||
|
2021
Q1 | $117K | Buy |
|
|||||
|
2020
Q4 | $0 | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $0 | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $145K | Sell |
|
|||||
|
2019
Q2 | $688K | Sell |
|
|||||
|
2019
Q1 | $2.78M | Buy |
|
|||||
|
2018
Q4 | $46K | Sell |
|
|||||
|
2018
Q3 | $979K | Sell |
|
|||||
|
2018
Q2 | $1.59M | Sell |
|
|||||
|
2018
Q1 | $1.11M | Buy |
|
|||||
|
2017
Q4 | $898K | Buy |
|
|||||
|
2017
Q3 | $84K | Buy |
|
|||||
|
2017
Q2 | $24K | Sell |
|
|||||
|
2017
Q1 | $25K | Sell |
|
|||||
|
2016
Q4 | $24K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $6K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $253K | Buy |
|